Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.National Institutes of Health (NIH) has extended its agreement with BioFocus, a service division of Galapagos, for the operation of the Molecular Libraries Small Molecule Repository (MLSMR) through December 2012.
Subscribe to our email newsletter
As per the terms of the agreement, with this two year extension, Galapagos is expected to be eligible to receive up to $8.6m.
BioFocus runs a compound management facility for a number of industrial and US government customers out of its Compound Focus, subsidiary in South San Francisco.
BioFocus said that the facility acquires and stores compounds under the NIH contract and distributes these compounds for high-throughput biological screening throughout the NIH’s academic network in the US.
Onno van de Stolpe, CEO of Galapagos, said: “We are pleased that the NIH has exercised its option to extend its collaboration with BioFocus’ compound management facility for another two years.”
Galapagos is a biotechnology company specialised in the discovery and development of small molecule and antibody therapies with new modes-of-action.